Abstract:Background and objectives: In this paper, we developed a significant class of control issues regulated by nonlinear fractal order systems with input and output signals, our goal is to design a direct transcription method with impulsive instant order. Recent advances in the artificial pancreas system provide an emerging treatment option for type 1 diabetes. The performance of the blood glucose regulation directly relies on the accuracy of the glucose-insulin modeling. This work leads to the monitoring and assessment of comprehensive type-1 diabetes mellitus for controller design of artificial panaceas for the precision of the glucose-insulin glucagon in finite time with Caputo fractional approach for three primary subsystems. Methods: For the proposed model, we admire the qualitative analysis with equilibrium points lying in the feasible region. Model satisfied the biological feasibility with the Lipschitz criteria and linear growth is examined, considering positive solutions, boundedness and uniqueness at equilibrium points with Leray–Schauder results under time scale ideas. Within each subsystem, the virtual control input laws are derived by the application of input to state theorems and Ulam Hyers Rassias. Results: Chaotic Relation of Glucose insulin glucagon compartmental in the feasible region and stable in finite time interval monitoring is derived through simulations that are stable and bounded in the feasible regions. Additionally, as blood glucose is the only measurable state variable, the unscented power-law kernel estimator appropriately takes into account the significant problem of estimating inaccessible state variables that are bound to significant values for the glucose-insulin system. The comparative results on the simulated patients suggest that the suggested controller strategy performs remarkably better than the compared methods. Conclusion: In the model under investigation, parametric uncertainties are identified since the glucose, insulin, and glucagon system's parameters are accurately measured numerically at different fractional order values. In terms of algorithm resilience and Caputo tracking in the presence of glucagon and insulin intake disturbance to maintain the glucose level. A comprehensive analysis of numerous difficult test issues is conducted in order to offer a thorough justification of the planned strategy to control the type 1 diabetes mellitus with designed the artificial pancreas.

Approaches to Modeling Blood Glucose Dynamics In Type 1 Diabetic Patients for Insulin Pump Automation

Gaussian Process-Based Model Predictive Control of Blood Glucose for Patients with Type 1 Diabetes Mellitus

Modeling Physical Activity Impact on Glucose Dynamics in People with Type 1 Diabetes for a Fully Automated Artificial Pancreas

Design of reduced multiple model predictive controller for glucose–insulin regulation in type 1 diabetic patients

Automated Insulin Delivery for Type 1 Diabetes Mellitus Patients using Gaussian Process-based Model Predictive Control

Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus

Learning Insulin-Glucose Dynamics in the Wild

A Backstepping‐Based Nonlinear Controller for Glucose‐Insulin System Dynamics in Type‐1 Diabetes Patients

Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility

Dynamic modeling of the glucose–insulin system with inhibitors impulsive control

Simultaneous model predictive control and moving horizon estimation for blood glucose regulation in Type 1 diabetes

Glucose-insulin mathematical model for the combined effect of medications and life style of Type 2 diabetic patients

Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothing

PID Control of Glucose Concentration in Subjects with Type 1 Diabetes Based on a Simplified Model: an in Silico Trial

Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control‐based approach

Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System

A New Insulin-Glucose Metabolic Model of Type 1 Diabetes Mellitus: an in Silico Study

Empirical dynamic model identification for blood-glucose dynamics in response to physical activity

A Simple Modeling Framework For Prediction In The Human Glucose-Insulin System

Computational techniques to monitoring fractional order type-1 diabetes mellitus model for feedback design of artificial panaceas

Generative deep learning for the development of a type 1 diabetes simulator